Would you trust a COVID-19 vaccine made available to the public by 2021?

COVID-19 vaccine

COVID-19 continues to be a healthcare focus as we enter autumn with organisations around the world racing towards a COVID-19 vaccine.

COVID-19 continues to be a healthcare focus as we enter autumn with organisations around the world racing towards a COVID-19 vaccine. Vaccine development and testing usually takes much longer, but this month, the University Of Oxford’s vaccine expanded into US Phase III clinical trials with 30,000 volunteers.

In Russia, the Sputnik V vaccine was approved prior to the completion of phases 1 and 2, and before phase 3 had started.

Britain has already signed deals for more than 340 million doses of a coronavirus vaccine that is likely to be provided in the second half of 2021. Some experts are concerned that the vaccines developed and brought to market for COVID-19 will be risky due to condensed testing and unknown long-term effects.

In September, we asked our panel members in the United Kingdom, Germany and Spain: “Would you trust a COVID-19 vaccine made available to the public by 2021?”. 

United Kingdom

Germany

Spain

Have your voice heard on relevant healthcare topics.

Join today and take part in paid market research studies!

Leave a Reply